Literature DB >> 18990140

Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma.

Giuseppe Simone1, Rocco Papalia, Andrea Loreto, Costantino Leonardo, Steno Sentinelli, Michele Gallucci.   

Abstract

OBJECTIVE: To identify significant prognostic indicators of upper urinary tract (UUT) urothelial carcinoma (UC) and to assess a risk stratification of patients. PATIENTS AND METHODS: We retrospectively analysed data from 162 patients with non-metastatic UC primarily occurring in UUT treated with open nephroureterectomy. Variables assessed included age, gender, pT, tumour grade, tumour necrosis extension, pN, tumour location, multifocal location, tumour diameter, and subsequent development of a bladder tumour. Tumour necrosis was measured using commercial software (Eureka interface system, version 4.0.22, HESP technology, Menarini Diagnostics, Italy) and was classified as none, focal (<10% of tumour area) or extensive, >or=10% of tumour area). The prognostic significance of each variable on metastasis-free survival (MFS) and disease-free survival (DFS) was tested in univariable analysis with the log-rank test. Variables with significance levels of P < 0.05 according to the univariable analyses were entered into a multivariable forward-stepwise Cox regression model.
RESULTS: At a mean follow-up of 66 months, 20 cancer-related deaths (12.3%) were censored. In multivariable analysis, tumour diameter, pT stage and tumour necrosis were independent predictors of MFS and DFS. All events occurred in patients with extensive tumour necrosis and a tumour diameter of >or=3 cm. The median survival of patients with advanced-stage tumours, extensive necrosis and a tumour diameter of >or=3 cm were significantly impaired by increasing pT stage(P < 0.001).
CONCLUSION: Tumour necrosis and tumour diameter are compelling prognostic factors that deserve further study in a prospective setting to determine if their use in combination with more traditional variables, such as pT stage, might better determine prognosis and guide the follow-up and treatment of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18990140     DOI: 10.1111/j.1464-410X.2008.08134.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  20 in total

1.  Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma.

Authors:  Anil Kapoor; Christopher B Allard; Peter Black; Wassim Kassouf; Christopher Morash; Ricardo Rendon
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  [Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma].

Authors:  R Z Ma; H Z Xia; M Lu; Z Y Zhang; Q M Zhang; J Lu; G L Wang; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

3.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

Review 4.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

5.  Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.

Authors:  Sima Porten; Arlene O Siefker-Radtke; Lianchun Xiao; Vitaly Margulis; Ashish M Kamat; Christopher G Wood; Eric Jonasch; Colin P N Dinney; Surena F Matin
Journal:  Cancer       Date:  2014-03-13       Impact factor: 6.860

6.  C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy.

Authors:  Yoshihiro Wada; Yoshihiro Maeda; Tatsuko Kubo; Ken Kikuchi; Masatoshi Eto; Takahisa Imamura
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

7.  The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma.

Authors:  Dragica Milenkovic-Petronic; Bogomir Milojevic; Milan Djokic; Sandra Sipetic-Grujicic; Isidora Grozdic Milojevic; Uros Bumbasirevic; Zoran Dzamic
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

Review 8.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

9.  The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.

Authors:  Qi Tang; Gengyan Xiong; Xuesong Li; Dong Fang; Chenguang Xi; Lei Zhang; Kaiwei Yang; Lin Yao; Cuijian Zhang; Wei Yu; Qun He; Kan Gong; Zhisong He; Liqun Zhou
Journal:  World J Urol       Date:  2015-10-24       Impact factor: 4.226

10.  Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.

Authors:  Kristian Krpina; Emina Babarović; Josip Španjol; Gordana Đorđević; Tobias Maurer; Nives Jonjić
Journal:  Wien Klin Wochenschr       Date:  2015-12-11       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.